DUBLIN, Dec. 20, 2019 /PRNewswire/ — The “Global Opportunities in Cerebral Embolization Markets” report has been added to ResearchAndMarkets.com’s offering.
Although the number of cerebral embolization procedures performed globally is fairly limited relative to many other interventions, the associated product sales are impressive: estimated at $1.75 billion globally in 2018, representing roughly $11,300 per procedure.
These high outlays – which include not only the specialized coils, liquid embolics, flow diverters and stent-assisted coil devices but also the microcatheters, micro guidewires, access devices, micro-occluding balloons and other devices employed ancillary to them – reflect two major factors.
The first is the specialized micro nature of neuro-interventional products, which creates design and quality control challenges for manufacturers. The second is the limited number of procedures, which precludes the production economies of scale necessary to attract new suppliers and support competitive pricing. In essence, neurointerventional products carry premium prices because they are premium products. Even the fairly recent influx of new flow diversion products did not create downward pricing pressure in that segment as expected; rather, pricing increased slightly.
Thus, we have not incorporated an expectation of downward pricing pressure into our forecast for cerebral embolization products as procedure volumes are not expected to reach a critical mass. Nevertheless, product sales are projected to increase at an 8% real annual rate through 2023 to $2.58 billion, representing nearly $12,000 per procedure.
Competitors covered in this analysis include:
- Acandis
- BALT
- J&J Cerenovus
- Medtronic
- MicroPort Medical
- Penumbra
- Phenox
- Rapidmedical
- Stryker
- Terumo MicroVention
- Others
Key Topics Covered
Executive Summary
- Cerebral Embolization Procedures
- Embolization Products Market
- Supplier Shares
1. Etiology & Epidemiology of Acute Stroke
1.1 Overview of the Brain
1.1.1 Cerebral Arterial Blood Supply
1.2 Etiology of Stroke
1.2.1 Ischemic Stroke
1.2.1.1 Causative Mechanisms
1.2.1.2 Symptoms
1.2.1.3 Risk Factors
1.2.1.4 Diagnosis
1.2.1.5 Treatment
1.2.1.6 Incidence
1.2.2 Hemorrhagic Stroke
1.2.2.1 Intracerebral Hemorrhage
1.2.2.1.1 Symptoms
1.2.2.1.2 Diagnosis and Treatment
1.2.2.2 Subarachnoid Hemorrhage
1.2.2.2.1 Causes and Risk Factors
1.2.2.2.2 Symptoms
1.2.2.2.3 Diagnosis
1.2.2.2.4 Treatment
1.2.2.3 Incidence
2. Embolization Approaches to Stroke Management
2.1 Hemorrhagic Stroke Targeted Pathologies
2.1.1 Intracranial Aneurysms
2.1.2 Arteriovenous Malformations (AVMs)
2.2 Management Options
2.2.1 Surgical Repair
2.2.2 Endovascular Embolization
2.2.2.1 Microcoil Systems
2.2.2.2 Liquid Embolic Systems
2.2.2.3 Coil-Containing Stent Systems
2.2.2.4 PVA Particles and Beads
2.2.2.5 Neurovascular Occlusion Balloons
2.2.2.6 Occlusion Meshes
2.2.2.7 Flow Diverting Embolization Systems
2.3 Procedures
3. Product Markets
3.1 Market by Major Segment
3.1.1 Aneurysm Embolics and Associated Devices
3.1.2 AVM Embolics and Associated Devices
3.1.3 Supplier Shares
3.2 Market by Major Geography
For more information about this report visit https://www.researchandmarkets.com/r/p6zi7v
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
